Hemolytic-uremic syndrome classification: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:
{{CMG}}; {{AE}}  
{{CMG}}; {{AE}}  
==Overview==
==Overview==
There is no established system for the classification of [disease name].
HUS may be classified according etiology  tinto 4 subtypes:
 
*HUS (D+HUS) <ref name=":0" />  
OR
*non-diarrhea-associated HUS (D−HUS) that  also called atypical HUS<ref name=":0" />
 
*''Streptococcus pneumoniae''‐associated HUS<ref name="KarpmanLoos2017" />
HUS may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
*Diacylglycerol kinase‐ε (DGKE)‐associated HUS<ref name="KarpmanLoos2017" />
 
OR
 
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
 
OR
 
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
 
OR
 
If the staging system involves specific and characteristic findings and features:
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
 
OR
 
The staging of [malignancy name] is based on the [staging system].
 
OR
 
There is no established system for the staging of [malignancy name].


==Classification==
==Classification==

Revision as of 18:43, 27 July 2018

Hemolytic-uremic syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemolytic-uremic syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemolytic-uremic syndrome classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemolytic-uremic syndrome classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemolytic-uremic syndrome classification

CDC on Hemolytic-uremic syndrome classification

Hemolytic-uremic syndrome classification in the news

Blogs on Hemolytic-uremic syndrome classification

Directions to Hospitals Treating Hemolytic-uremic syndrome

Risk calculators and risk factors for Hemolytic-uremic syndrome classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

HUS may be classified according etiology tinto 4 subtypes:

  • HUS (D+HUS) [1]
  • non-diarrhea-associated HUS (D−HUS) that also called atypical HUS[1]
  • Streptococcus pneumoniae‐associated HUS[2]
  • Diacylglycerol kinase‐ε (DGKE)‐associated HUS[2]

Classification

Hemolytic uremic syndrome (HUS) may be classified according to diarrhea-associated into subtypes :[1][2]

  • HUS (D+HUS) [1]
  • non-diarrhea-associated HUS (D−HUS) that also called atypical HUS[1]
  • Streptococcus pneumoniae‐associated HUS[2]
  • Diacylglycerol kinase‐ε (DGKE)‐associated HUS[2]

References

  1. 1.0 1.1 1.2 1.3 1.4 Gaute Reier Jenssen, Eirik Hovland, Anna Bjerre, Hans-Jacob Bangstad, Karin Nygard & Line Vold (2014). "Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999-2008--a retrospective study of hospital records to assess the sensitivity of surveillance". BMC infectious diseases. 14: 265. doi:10.1186/1471-2334-14-265. PMID 24884396. Unknown parameter |month= ignored (help)
  2. 2.0 2.1 2.2 2.3 2.4 Karpman, Diana; Loos, Sebastian; Tati, Ramesh; Arvidsson, Ida (2017). "Haemolytic uraemic syndrome". Journal of Internal Medicine. 281 (2): 123–148. doi:10.1111/joim.12546. ISSN 0954-6820.

Template:WH Template:WS